nicorandil has been researched along with Coronary Artery Disease in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (21.62) | 29.6817 |
| 2010's | 22 (59.46) | 24.3611 |
| 2020's | 7 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Murohara, T | 1 |
| Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H | 2 |
| Tolunay, H | 1 |
| Chen, X; Jiang, Y; Luo, J; Mo, S; Rong, J; Xiao, X; Yi, B | 1 |
| Chen, M; Dai, W; Ding, C; Huang, X; Su, X; Zhang, Y; Zhu, W | 1 |
| He, Y; Song, X; Tian, J; Yang, X; Yong, J; Zhang, L; Zhao, X; Zuo, H | 1 |
| Iizuka, T; Kawazoe, M; Mikamo, H; Noro, M; Sato, S; Shimizu, K; Shirai, K; Takahashi, M | 1 |
| Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
| Doi, M; Ejiri, K; Ito, H; Kawakita, N; Kohno, K; Miyoshi, T; Munemasa, M; Murakami, M; Nakahama, M; Nakamura, K | 1 |
| Doi, M; Ejiri, K; Ito, H; Kohno, K; Miyoshi, T; Munemasa, M; Murakami, M; Nakahama, M; Nakamura, K; Takaishi, A | 1 |
| Li, Y; Liu, H; Peng, W; Song, Z | 1 |
| Gostishchev, RV; Minasyan, AA; Rogoza, AN; Samko, AN; Soboleva, GN | 1 |
| Liu, QJ; Zhang, CF; Zhao, XT | 1 |
| Du, L; Li, J; Liu, G; Yao, X; Yu, Q; Zhang, X | 1 |
| Hashimoto, T; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Okino, K; Ono, T; Sato, N; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Giliarevskiĭ, SR; Golshmid, MV; Kuz'mina, IM; Rezvan, VV | 1 |
| Biscaglia, S; Valgimigli, M | 1 |
| Hashimoto, T; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Ono, T; Sato, N; Takatani, T; Yamazaki, S | 1 |
| Amano, T; Doh, JH; Kato, D; Kim, HS; Koo, BK; Kurita, A; Lim, WH; Nam, CW; Oi, M; Park, JJ; Park, KW; Pijls, NH; Takashima, H; Toyofuku, M; van Nunen, L; Waseda, K; Yang, HM | 1 |
| Beleslin, B; Djordjevic-Dikic, A; Dobric, M; Kostic, J; Milasinovic, D; Nedeljkovic, M; Ostojic, M; Radosavljevic-Radovanovic, M; Stepanovic, J; Stojkovic, S; Tesic, M; Trifunovic, Z; Zamaklar-Tifunovic, D | 1 |
| Chatzizisis, YS; Giannoglou, GD; Giannopoulos, AA | 1 |
| Doi, M; Ejiri, K; Enko, K; Hirami, R; Hosogi, S; Ito, H; Kawai, Y; Kohno, K; Mima, A; Miyoshi, T; Munemasa, M; Murakami, M; Nakahama, M; Nakamura, K; Nanba, S; Oka, T; Sakuragi, S; Sato, K; Sato, T; Takahashi, N; Takaishi, A | 1 |
| Hejazi, SF; Iranirad, L; Jang, SA; Sadeghi, MS | 1 |
| Horinaka, S; Ishimitsu, T; Kohro, T; Nagai, R; Suzuki, S; Yabe, A; Yagi, H; Yamazaki, T | 1 |
| Battler, A; Dvir, D | 1 |
| Araki, S; Izumiya, Y; Kaikita, K; Kojima, S; Matsubara, J; Nagayoshi, Y; Ogawa, H; Sakamoto, K; Sugiyama, S; Tsujita, K; Usuku, H | 1 |
| Köster, R; Meinertz, T | 1 |
| Doh, JH; Jang, HJ; Kim, HS; Kim, JH; Koo, BK; Lee, HS; Nam, CW; Park, JB; Park, KW; Seo, MK; Yang, HM | 1 |
| Kaikita, K; Kojima, S; Miyamoto, S; Ogawa, H; Sakamoto, T; Sugiyama, S; Yoshimura, M | 1 |
| Ichiro, I; Kenji, N; Masaharu, I; Masashi, Y; Satoshi, K; Suji, N; Takashi, U; Takuji, K; Yuji, S | 1 |
| Hato, K; Kawase, Y; Nishimoto, M; Okajima, K; Yoshikawa, J | 1 |
| Chujo, M; Higgins, CB; Krombach, GA; Saeed, M | 1 |
| Hina, K; Hirohata, S; Hirota, M; Iwasaki, K; Kamikawa, S; Kusachi, S; Murakami, M; Sangawa, M; Shiratori, Y; Yamamoto, K | 1 |
| Cheon, WS; Cho, GY; Choi, YJ; Kim, EJ; Kim, MK; Kim, SH; Park, WJ; Rhim, CY | 1 |
| Fujiwara, H; Hirose, T; Iwama, M; Kojima, T; Matsuo, H; Minatoguchi, S; Ono, K; Segawa, T; Takahashi, H; Warita, S; Watanabe, S; Watanabe, T | 1 |
| Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY | 1 |
10 review(s) available for nicorandil and Coronary Artery Disease
| Article | Year |
|---|---|
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2019 |
Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Topics: Aged; Coronary Artery Disease; Elective Surgical Procedures; Female; Heart Injuries; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials.
Topics: Angina, Stable; Anti-Arrhythmia Agents; Contrast Media; Coronary Artery Disease; Humans; Kidney Diseases; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic | 2018 |
Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Topics: Aged; Biomarkers; Cardiovascular Agents; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Recovery of Function; Stroke Volume; Treatment Outcome; Troponin I; Ventricular Function, Left | 2019 |
Effects of Nicorandil on All-Cause Mortality and Cardiac Events in CAD Patients Receiving PCI.
Topics: Cause of Death; Coronary Artery Disease; Global Health; Humans; Nicorandil; Percutaneous Coronary Intervention; Prognosis; Survival Rate; Vasodilator Agents | 2019 |
[The role of alternative approaches to antiischemic therapy in patients with stable coronary artery disease].
Topics: Coronary Artery Disease; Humans; Nicorandil; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents | 2013 |
Stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vasospasm; Echocardiography, Stress; Exercise Test; Humans; Ivabradine; Microvessels; Nicorandil; Nitrates; Percutaneous Coronary Intervention; Piperazines; Ranolazine; Smoking Cessation; Vasodilator Agents | 2014 |
Pharmacological approaches of refractory angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nicorandil; Nitrates; Ranolazine | 2016 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine | 2010 |
[New agents for the therapy of angina pectoris].
Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents | 2011 |
16 trial(s) available for nicorandil and Coronary Artery Disease
| Article | Year |
|---|---|
The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images: A study protocol.
Topics: Anxiety; Coronary Artery Disease; Coronary Vessels; Depression; Drugs, Chinese Herbal; Female; Humans; Male; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic | 2020 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
Topics: Aged; Coronary Artery Disease; Coronary Vessels; Creatine Kinase, MB Form; Female; Heart Injuries; Humans; Ischemic Preconditioning, Myocardial; Kaplan-Meier Estimate; Logistic Models; Nicorandil; Odds Ratio; Percutaneous Coronary Intervention; Pregnancy; Proportional Hazards Models; Protective Agents; Treatment Outcome | 2018 |
Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Angina, Stable; Coronary Artery Disease; Female; Heart Injuries; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardium; Nicorandil; Percutaneous Coronary Intervention | 2018 |
The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Topics: Aged; Cardiotonic Agents; Coronary Artery Disease; Creatine Kinase, MB Form; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Intraoperative Complications; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Percutaneous Coronary Intervention; Pilot Projects; Treatment Outcome; Troponin I | 2018 |
Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Topics: Aged; Coronary Artery Disease; Death, Sudden, Cardiac; Fatty Acids; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicorandil; Percutaneous Coronary Intervention; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease.
Topics: Administration, Oral; Aged; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Fatty Acids; Female; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardium; Nicorandil; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2015 |
The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.
Topics: Cardiotonic Agents; Coronary Artery Disease; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Treatment Outcome; Ultrasonography | 2015 |
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Topics: Aged; Biomarkers; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Humans; Intraoperative Complications; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Percutaneous Coronary Intervention; Postoperative Complications; Treatment Outcome; Troponin T; Vasodilator Agents | 2017 |
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Iran; Kidney; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Prospective Studies; Renal Agents; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Nicorandil; Prognosis; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome | 2010 |
Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
Topics: Aged; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Drug Administration Routes; Feasibility Studies; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Male; Middle Aged; Nicorandil; Prospective Studies; Treatment Outcome; Vasodilator Agents | 2013 |
Assessment of coronary artery disease with nicorandil stress magnetic resonance imaging.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Echo-Planar Imaging; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicorandil; Time Factors; Vasodilator Agents | 2004 |
Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting.
Topics: Aged; Biomarkers; Cardiac Catheterization; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Humans; Incidence; Male; Nicorandil; Risk Assessment; Risk Factors; Stents; Troponin T; Vasodilator Agents | 2006 |
Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography.
Topics: Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicorandil; Prospective Studies; Radial Artery; Spasm; Vasodilator Agents; Verapamil | 2007 |
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
Topics: Aged; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Nicorandil; Prospective Studies; Treatment Outcome; Vasodilator Agents; Verapamil | 2007 |
11 other study(ies) available for nicorandil and Coronary Artery Disease
| Article | Year |
|---|---|
How Do We Improve the Utility of Fractional Flow Reserve? - For Precise Diagnosis of Myocardial Ischemia.
Topics: Coronary Artery Disease; Coronary Stenosis; Fractional Flow Reserve, Myocardial; Humans; Myocardial Ischemia; Nicorandil | 2019 |
Does Ranolazine Reduce Pain Perception With Cerebral Effect?
Topics: Acetanilides; Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Pain Perception; Randomized Controlled Trials as Topic; Ranolazine | 2020 |
Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials".
Topics: Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine | 2020 |
Nicorandil, a promising drug for the prevention of percutaneous coronary artery intervention-related myocardial injury and infarction in patients with stable coronary artery disease.
Topics: Arteries; Coronary Artery Disease; Humans; Infarction; Microcirculation; Nicorandil; Percutaneous Coronary Intervention | 2020 |
Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Topics: Aged; Angina, Stable; Coronary Artery Disease; Female; Heart Diseases; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Time Factors; Treatment Outcome; Vascular Stiffness; Vasodilator Agents | 2020 |
Variability of fractional flow reserve according to the methods of hyperemia induction.
Topics: Adenosine; Aged; Coronary Artery Disease; Coronary Circulation; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Purines; Pyrazoles; Radiography; Reproducibility of Results; Vasodilator Agents | 2015 |
Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angina Pectoris; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cardiovascular Agents; Cells, Cultured; Chi-Square Distribution; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Administration Schedule; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endothelial Cells; Fibrosis; Humans; Inflammation Mediators; Japan; Lipids; Logistic Models; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Molecular Chaperones; Necrosis; Nicorandil; Odds Ratio; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Artery Disease; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2004 |
Intracoronary administration of nicorandil for the treatment of spontaneous microvascular spasm with ST segment elevation.
Topics: Anti-Arrhythmia Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Electrocardiography; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nicorandil | 2004 |
Gadomer-enhanced MR imaging in the detection of microvascular obstruction: alleviation with nicorandil therapy.
Topics: Animals; Contrast Media; Coronary Artery Disease; Coronary Vessels; Gadolinium; Magnetic Resonance Imaging; Microcirculation; Nicorandil; Rats; Vasodilator Agents | 2005 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation | 2000 |